Araceli Biosciences

Tigard, OR · Founded 2020 · Privately Held (backing)

Developer of advanced imaging technologies intended to enhance the drug discovery process for researchers. Araceli Biosciences is based in Tigard, OR and was founded in 2020. It was valued at $27 million at its seed round in Nov 2025, the last priced event on record. It has raised $14.5 million across 2 recorded rounds; the latest was a $12.2 million early-stage round in Dec 2024.

PMV mark · valuation
$27.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$14.5M
Last round
Early Stage VC
Dec 2024

Who backs Araceli Biosciences?

2 investors
InvestorType
Fluke Venture PartnersFamily office
William Cortelyou—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Araceli Biosciences investors

2 investors are on record for Araceli Biosciences, including Fluke Venture Partners and William Cortelyou. The early-stage round in Dec 2024 drew 28 investors.

Free account
More of Araceli Biosciences with a free account
  • ·Watch Araceli Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 2 firms already write checks for companies like Araceli Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View